BIOCRYST PHARMACEUTICALS, INC. (BCRX) Operating income 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual operating income history from SEC filings — each fiscal year as reported.
$341.0MFY2025 · since FY2016: -$48.6M → $341.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $341.0M | +13508.9% |
| FY2024 | -$2.5M | +97.5% |
| FY2023 | -$103.7M | +30.1% |
| FY2022 | -$148.4M | +16.5% |
| FY2021 | -$177.7M | -1.7% |
| FY2020 | -$174.8M | -75.7% |
| FY2019 | -$99.5M | -5.6% |
| FY2018 | -$94.2M | -64.1% |
| FY2017 | -$57.4M | -18.1% |
| FY2016 | -$48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice